DD212391A3 - METHOD OF GENERATING (GAMMA-HIGH 32 P) ADENOSINE-5'-TRIPHOSPHATE HIGH SPECIFIC ACTIVITY - Google Patents
METHOD OF GENERATING (GAMMA-HIGH 32 P) ADENOSINE-5'-TRIPHOSPHATE HIGH SPECIFIC ACTIVITY Download PDFInfo
- Publication number
- DD212391A3 DD212391A3 DD23285481A DD23285481A DD212391A3 DD 212391 A3 DD212391 A3 DD 212391A3 DD 23285481 A DD23285481 A DD 23285481A DD 23285481 A DD23285481 A DD 23285481A DD 212391 A3 DD212391 A3 DD 212391A3
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- adenosine
- gamma
- atp
- triphosphate
- specific activity
- Prior art date
Links
Landscapes
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Verfahren zur Herstellung von (Gamma-hoch 32 P) Adenosin-5'-triphosphat (ATP) mit hoher spezifischer Aktivitaet der Formel I. Die Erfindung hat das Ziel, ein technisch einfaches, schnelles Verfahren zu entwickeln, das gute Ausbeuten liefert. Erfindungsgemaess wird in einem kleinen Ansatzvolumen Adenosin-5'-diphosphat im Mymol-Massstab unter bestimmten Konzentrationsverhaeltnissen entsprechender Substrate enzymatisch zu (Gamma-Hoch 32 P) ATP phosphoryliert. Nach kurzer Reaktionszeit kann das Produkt in einem einfachen Verfaren saeulenchromatographisch isoliert werden.Process for the preparation of (gamma-high 32 P) adenosine-5'-triphosphate (ATP) with high specific activity of the formula I. The object of the invention is to develop a technically simple, fast process which gives good yields. According to the invention, a small batch volume of adenosine-5'-diphosphate is enzymatically phosphorylated on the molar scale under certain concentration ratios of corresponding substrates (gamma-high 32 P) ATP. After a short reaction time, the product can be isolated by column chromatography in a simple procedure.
Description
Dr. E. Bauschke R. Berger ZfK M. Kießling ZfK H. KreißlDr. E. Bauschke R. Berger ZfK M. Kiessling ZfK H. Kreißl
"Verfahren zur Herstellung von /J- P/ Adenosin 5'-triphosphat hoher spezifischer Aktivität" "Method for producing / J- P / adenosine 5'-triphosphate of high specific activity"
Anwendungsgebiet der Erfindung Die Erfindung betrifft ein Verj Adenosin-5'-tripho^phat (ATP) der Formel IField of the Invention The invention relates to a verj adenosine 5'-triphosphate (ATP) of the formula I.
32 Die Erfindung betrifft ein Verfahren zur P-Markierung vonThe invention relates to a method for P-labeling of
0 0 0 θΟ-32_Ι_Ο-!_θ-|-Ο0 0 0 θ Ο-32_Ι_ Ο -! _ Θ- | -Ο
M+ = H+ oder andere Kationen.M + = H + or other cations.
Anwendungsgebiet sind die radiochemische Synthese und die Nucleotidchemie.Fields of application are radiochemical synthesis and nucleotide chemistry.
Bekannt sind in der Literatur eine Reihe von Verfahren, die es gestatten, Q- P-/ ATP zu erhalten.A number of methods are known in the literature which allow to obtain Q- P - / ATP.
Nach Waiseth (T. P. Walseth, R, A. Johnson Biochem et Biophys. Acta 5ji£ (1979) 11 - 31) wird durch Reaktion von 32P-Phosphat mit D-Glycerinaldehyd-3-phosphat, das durch Trioseisomerase aus Dihydrosyacetonphosphat dargestellt wurde, das gewünschte 1,3 Diphosphoglycerat hergestellt, das selbst mit Adenosin-5'-diphosphat (ADP) enzymatisch reagiert.According to Waiseth (TP Walseth, R, A. Johnson Biochem et Biophys., Acta 5 p., (1979) 11-31), reaction of 32 P-phosphate with D-glyceraldehyde-3-phosphate, which was prepared by triose isomerase from dihydrosyacetone phosphate, produced the desired 1,3-diphosphoglycerate, which itself enzymatically reacts with adenosine 5'-diphosphate (ADP).
»Hi» αλλ a. ,. ι\er ε: ι·*-*»Hi» αλλ a. . ι \ er ε: ι · * - *
232854 7232854 7
In. diesem. Ansatz, wird, ein sehr komplexes Enzymgemisch, eingesetzt. Enzyme sind, gegen ß-Strahlung- höherer" Intensität, sehr empfindlich. Daher wird, von Walseth. als obere radiochemischeIn. this. Approach is used, a very complex enzyme mixture. Enzymes are very sensitive to ß-radiation of higher intensity, so Walseth, as upper radiochemical
TO-TO-
Konzentration: 10 mCi H, P0«/50 All Reaktionsvolumen "be·* schrieben." : ' . .Concentration: 10 mCi H, P0 "/ 50 All reaction volumes". : '. ,
Ein wesentlich einfacheres Verfahren nach Gilbert, Mazam (W. Gilbert,; A. M- Maxam,. Labormitteilung und. I.. M. Glynn, J. "B.. Chappell.Biochem., ~<T. £0 ζ1964) 147 - 149) ergibt nicht so. hohe spezifische1 Aktivitäten-., - "·;.'·A much simpler method according to Gilbert, Mazam (W. Gilbert, A.M.Maxam, Laboratory Communication, and I.M. Glynn, J. "B. Chappell. Biochem.,"<T. £ 0 .1964) '·; 147 - "· - 149) does not result in such a high specific stop activity 1,...
Zur Synthese; von Zp- P/ ATP: niederer spezifischer Aktivität;, ein Verfahren von, R.' Gibbs, E. l/L. Röddy, E.. Titus1 CJ* -For synthesis; of Zp-P / ATP: lower specific activity ;, a method of 'R.' Gibbs, E.L / L. Röddy, E .. Titus 1 CJ * -
Biol. Chem. 240.(1965) 2181) veröffentlicht worden. " Eine Synthesevorschrift, für- ^f-- PJT ATP hoher spezifischer-Aktivität war-je.doch. nicht beschrieben: worden:Biol. Chem. 240 (1965) 2181). "A synthetic prescription for which high specific activity has not been described, however, has been:
Ziel, der- Erfindung · ·..'"' . ' ' Die Erfindung- hat: das.1 Ziel,, ein technisch, möglichst- einfaches Verfahren, zu: entwickeln,, das die- Herstellung: von, nmol-Mengen an- spezifisch hochmarkier tem. ffi- XJ ATP durch. Einwirkung . eines komplexen. Enzymgemisches. im kurzer Zeit gewährleistet.. . Aim DER invention · .. '''''The Erfindung- has: the one goal ,, technically, möglichst- simple method:. ,, develop the production DIE: to from, nmol amounts -. hochmarkier specific system FFI XJ ATP by the action of a complex enzyme mixture in a short time ensured ......
Darlegung des· Wesens der Erfindung: .·.-.. .: Erfindungsgemäß werden Verbindungen, der Formel. X hergestellt, indem: man: in einem Eintopfverfahren, die: entsprechende- Aktivi- Presentation of the essence of the invention : According to the invention are compounds of the formula. X prepared by: man: in a one-pot process, the:
32"32 "
tätsmenge an trägerfreier H-, PO,, welche: zuvor lyophilisiert worden ist, in einem. Substratgemisch aufnimmt.. Die Reaktion wird durch Zugabe speziell, gereinigter Enzyme gestartet und nach einigen. Minuten z. B'.. durch Ethanol gestoppt... Hach Lyophilisation und Wiederaufnahme in. etwas Wasser wird das Reaktionsgemisch auf. eine Anionenaustauscher-Säule, z. B.. DEAE-Sephadex: A 25V: gegeben und durch Elution das gewünschte Produkt isoliert- E±ne^ Hochleistungsflüssigchromatographie-Trennung an reversed phase ist ebenfalls möglich..amount of carrier-free H-, PO ,, which: has been previously lyophilized, in one. Substrate mixture receives .. The reaction is started specifically, purified enzymes by the addition and after a few. Minutes z. B '.. stopped by ethanol ... Hach lyophilization and recovery in. Some water, the reaction mixture on. an anion exchange column, e.g. B .. DEAE-Sephadex: A 25V: added and the desired product isolated by elution - E ^ ne ^ High performance liquid chromatography separation at reversed phase is also possible.
UHUJUHUJ
Das folgende Ausführungsbeispiel erläutert die Erfindung näher., ' . .The following embodiment explains the invention in more detail. ,
925 MBg. trägerfreier E3 32PO4 CROTOP-H3 32PQ4, ZfK-Rossendorf) wurden in einem. Plastikröhrchen. lyophilisiert» Das lyophilisat wurde in. 80 All. eines Substratgemisches aufgenommen, das· 60 mit an TRIS/EC1; pH = 8;. 0,6.mffi an Nicotinamid-adenin-dinucleotid; 0,37 mM'an. ADP;. 0,-58 mM Fructose-1, 6-diphosphatr 1.5· naM an, MgCl2; 1,3 mit an Chelaplex III war·. Dazu wurden. TOO; /Ug- des Ehzymgemisches von Aldolase, Phosphoglycerat- -kinase., Glyßeraldehydphosphatdehydrogenase (Massenverhältnis 2 :·. .1' : 2) in.-1'O; /Ul 0,:1 M TRIS/HCl-Puff er,. "pH - 8, gegeben.. 'Fach 5 Minuten wurde das Gemisch, mit. 300 yul absolutem. Ethanol-versetzt.. Die Df *2j ATP -Ausbeut e war* größer als 80 %... Uach Lyophilisation, und. Aufnahme, des Rückstandes in 0,.5^ml H2O wird auf. eine DEAE-Sephadex A 25-Säule in (HCO3")' Form aufgetragen und mit. kontinuierlichem Gradienten TOO ml HpO zu. 100 ml T K Triäthylammoniumbicarbonatlösung eluiert... Dia. Dimension, der Säule, betrug 1 χ 10 cm.925 MBg. carrier-free E 3 32 PO 4 CROTOP-H 3 32 PQ 4 , ZfK-Rossendorf) were in a. Plastic tubes. lyophilized »The lyophilisate was in. 80 All. of a substrate mixture containing 60% of TRIS / EC1; pH = 8; 0.6.mffi of nicotinamide adenine dinucleotide; 0.37 mM. ADP ;. 0, -58mM Fructose-1, 6-diphosphate 1.5 x NaM an, MgCl2; 1.3 with at Chelaplex III was ·. In addition were. TOO; / Ug- of the egg mixture of aldolase, phosphoglycerate kinase., Glyceraldehyde phosphate dehydrogenase (mass ratio 2: · .1 ': 2) in.-1'O; / Ul 0, 1 M TRIS / HCl Puff he ,. The mixture was mixed for 5 minutes with 300 yl of absolute ethanol. The Df * 2j ATP yield was greater than 80% after lyophilization, and uptake of the residue in 0.55 ml of H 2 O is applied to a DEAE-Sephadex A 25 column in (HCO 3 ") 'form and mixed with. continuous gradient TOO ml HpO. 100 ml of T K triethylammonium bicarbonate solution eluted ... Dia. Dimension, the column was 1 χ 10 cm.
Zwischen; 110: -120 ml, wurde eine Fraktion, aufgefangen, die- '' ΈΖ &.ΤΈ mit einer radiochemischen Reinheit-von. 98 % enthielt.. · ;Between; 110: -120 ml, a fraction was collected which contained the '' ΈΖ &. ' With a radiochemical purity of. 98 % contained .. ·;
Die Produktcharakterisijerung erfolgte dünnschichtchromatographisch mit. inaktivem ATP als Vergleich.The product characterization was carried out by thin-layer chromatography. inactive ATP as a comparison.
Rrv = 0,28 -auf" Polyethylenimin-Cellulose Fertigplatten der Fa.Rrv = 0.28 - on "polyethyleneimine cellulose precoat plates of Fa.
Merck . ' Merck. '
Laufmittel: 0,5 MKH2PO4, pH= 3,5-Eluent: 0.5 MKH 2 PO 4 , pH = 3.5
Claims (1)
plex ΙΙΓ,ί mit trägerfreier H3 PO4 innerhalb von 2 - 15 Minu ten durch ein Enzyrasystera,. bestehend aus Aldolase, Phosphoglyceratkinasei; Glyceraldehydphosphatdehydrogenase enzymatisch phosphorylierir wird* 32
plex ΙΙΓ, ί with unsupported H 3 PO 4 within 2 - 15 minutes through an enzyme cycle. consisting of aldolase, phosphoglycerate kinasei; Glyceraldehyde phosphate dehydrogenase becomes phosphorylated enzymatically *
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD23285481A DD212391A3 (en) | 1981-08-28 | 1981-08-28 | METHOD OF GENERATING (GAMMA-HIGH 32 P) ADENOSINE-5'-TRIPHOSPHATE HIGH SPECIFIC ACTIVITY |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD23285481A DD212391A3 (en) | 1981-08-28 | 1981-08-28 | METHOD OF GENERATING (GAMMA-HIGH 32 P) ADENOSINE-5'-TRIPHOSPHATE HIGH SPECIFIC ACTIVITY |
Publications (1)
Publication Number | Publication Date |
---|---|
DD212391A3 true DD212391A3 (en) | 1984-08-08 |
Family
ID=5533175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD23285481A DD212391A3 (en) | 1981-08-28 | 1981-08-28 | METHOD OF GENERATING (GAMMA-HIGH 32 P) ADENOSINE-5'-TRIPHOSPHATE HIGH SPECIFIC ACTIVITY |
Country Status (1)
Country | Link |
---|---|
DD (1) | DD212391A3 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2585724A1 (en) * | 1985-08-01 | 1987-02-06 | Centre Nat Rech Scient | ENZYMATIC MARKING KIT FOR NUCLEOSIDES TRIPHOSPHATES AND PROCESS FOR THE PREPARATION OF NUCLEOTIDES TRIPHOSPHATES MARKED AT 32P OR 35S |
FR2729944A1 (en) * | 1995-01-27 | 1996-08-02 | Isotopchim Sarl | Prodn. of gamma-radio-labelled nucleoside tri-phosphate |
-
1981
- 1981-08-28 DD DD23285481A patent/DD212391A3/en unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2585724A1 (en) * | 1985-08-01 | 1987-02-06 | Centre Nat Rech Scient | ENZYMATIC MARKING KIT FOR NUCLEOSIDES TRIPHOSPHATES AND PROCESS FOR THE PREPARATION OF NUCLEOTIDES TRIPHOSPHATES MARKED AT 32P OR 35S |
EP0214014A1 (en) * | 1985-08-01 | 1987-03-11 | Centre National De La Recherche Scientifique (Cnrs) | Kit for the enzymatic labelling of nucleoside triphosphates, and process for the preparation of nucleoside triphosphates labelled with 32P or 35S with 32PO4H3 or 35S-PO3Na3 |
FR2729944A1 (en) * | 1995-01-27 | 1996-08-02 | Isotopchim Sarl | Prodn. of gamma-radio-labelled nucleoside tri-phosphate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2122529C2 (en) | ||
Moffatt et al. | Nucleoside Polyphosphates. X. 1 The Synthesis and Some Reactions of Nucleoside-5'Phosphoromorpholidates and Related Compounds. Improved Methods for the Preparation of Nucleoside-5'Polyphosphates1 | |
Khorana | Carbodiimides. Part V. 1 A Novel Synthesis of Adenosine Di-and Triphosphate and P1, P2-Diadenosine-5'-pyrophosphate | |
DE3529478A1 (en) | 7-DESAZA-2'DESOXYGUANOSINE NUCLEOTIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR NUCLEIC ACID SEQUENCING | |
Hall et al. | Nucleoside Polyphosphates. III. 1 Syntheses of Pyrimidine Nucleoside-2'(3'), 5'-diphosphates | |
DE2627156A1 (en) | PURINE SUGAR DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
DE2833940A1 (en) | PREPARATIONS CONTAINING S-ADENOSYL-L-METHIONINE, WHICH ARE STABILIZED AGAINST A DEGRADATION OF THE ACTIVE INGREDIENT COMPONENTS, AND MANUFACTURING METHODS FOR THESE PREPARATIONS | |
Borden et al. | Nucleotide Synthesis. III. Preparation of Nucleoside-3', 5'Cyclic Phosphates in Strong Base1, 2 | |
DE1695303A1 (en) | Process for the preparation of nucleoside 5'-diphosphates and triphosphates as well as mono- and oligonucleotidyl nucleside-5'-diphosphates and triphosphates | |
Drummond et al. | Deoxyribonucleoside-3′, 5′ Cyclic Phosphates. Synthesis and Acid-Catalyzed and Enzymic Hydrolysis | |
DE60021629T2 (en) | Dinucleotide crystals | |
US3852266A (en) | Process for producing 5-iodo-deoxy-uridine | |
van Boom et al. | The synthesis of oligoribonucleotides. Part X. Preparation of 2′, 3′-cyclic phosphates of ribonucleosides and diribonucleoside phosphates via phosphotriester intermediates | |
DE1918282A1 (en) | Process for the preparation of diesters of condensed phosphoric acid | |
EP0131942B1 (en) | Anthracycline derivatives, method for their preparation and their use as cytostatic agents | |
DD212391A3 (en) | METHOD OF GENERATING (GAMMA-HIGH 32 P) ADENOSINE-5'-TRIPHOSPHATE HIGH SPECIFIC ACTIVITY | |
DE2352163A1 (en) | PROCESS FOR PRODUCING A REACTIVE MATRIX FROM A COENZYME CHEMICALLY CONNECTED TO A WATER-INSOLUBLE CARRIER MATERIAL | |
EP0721372B1 (en) | Nucleoside-containing sorbent for affinity chromatography | |
DE3626915A1 (en) | METHOD FOR THE ENZYMATIC SYNTHESIS OF A TRISACCHARID CONTAINING N-ACETYLNEURAMINE ACID | |
DE2308801A1 (en) | PROCESS FOR PREPARING NUCLEOSIDE 5'-DIPHOSPHATE-AETHANOLAMINES | |
DE4123993A1 (en) | IMPROVED METHOD FOR PRODUCING THE MONONATRIUM SALT OF RIBOFLAVIN 5'-PHOSPHATE | |
WO1993011144A1 (en) | New method of preparing 2-fluoropurine derivatives | |
DE19618727C2 (en) | Preparation of alkylated nucleoside 3'-phosphates | |
DD213223A1 (en) | PROCESS FOR PREPARING / ALPHA HIGH 32 P / NUCLEOSIDE 5'-PHOSPHATES OF HIGH SPECIFIC ACTIVITY | |
DD153873A1 (en) | PROCESS FOR THE PREPARATION OF NUCLEOSIDE 5'-MONOPHOSPHATES |